234 related articles for article (PubMed ID: 33689164)
1. Differentiation of Human Induced Pluripotent Stem Cells (hiPSC) into Endothelial-Type Cells and Establishment of an In Vitro Blood-Brain Barrier Model.
Li Y; Terstappen GC; Zhang W
Methods Mol Biol; 2022; 2454():521-530. PubMed ID: 33689164
[TBL] [Abstract][Full Text] [Related]
2. Development of Human in vitro Brain-blood Barrier Model from Induced Pluripotent Stem Cell-derived Endothelial Cells to Predict the in vivo Permeability of Drugs.
Li Y; Sun X; Liu H; Huang L; Meng G; Ding Y; Su W; Lu J; Gong S; Terstappen GC; Zhang R; Zhang W
Neurosci Bull; 2019 Dec; 35(6):996-1010. PubMed ID: 31079318
[TBL] [Abstract][Full Text] [Related]
3. An hiPSC-Derived In Vitro Model of the Blood-Brain Barrier.
Goodwin-Trotman M; Patel K; Granata A
Methods Mol Biol; 2022; 2492():103-116. PubMed ID: 35733040
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of Human Induced Pluripotent Stem Cells to Brain Microvascular Endothelial Cell-Like Cells with a Mature Immune Phenotype.
Matsuo K; Engelhardt B; Nishihara H
J Vis Exp; 2023 May; (195):. PubMed ID: 37318257
[TBL] [Abstract][Full Text] [Related]
5. High and low permeability of human pluripotent stem cell-derived blood-brain barrier models depend on epithelial or endothelial features.
Girard SD; Julien-Gau I; Molino Y; Combes BF; Greetham L; Khrestchatisky M; Nivet E
FASEB J; 2023 Feb; 37(2):e22770. PubMed ID: 36688807
[TBL] [Abstract][Full Text] [Related]
6. Recent progress and new challenges in modeling of human pluripotent stem cell-derived blood-brain barrier.
Yan L; Moriarty RA; Stroka KM
Theranostics; 2021; 11(20):10148-10170. PubMed ID: 34815809
[TBL] [Abstract][Full Text] [Related]
7. Human iPSC-Derived Blood-Brain Barrier Models: Valuable Tools for Preclinical Drug Discovery and Development?
Appelt-Menzel A; Oerter S; Mathew S; Haferkamp U; Hartmann C; Jung M; Neuhaus W; Pless O
Curr Protoc Stem Cell Biol; 2020 Dec; 55(1):e122. PubMed ID: 32956578
[TBL] [Abstract][Full Text] [Related]
8. Establishment of an in Vitro Human Blood-Brain Barrier Model Derived from Induced Pluripotent Stem Cells and Comparison to a Porcine Cell-Based System.
Di Marco A; Vignone D; Gonzalez Paz O; Fini I; Battista MR; Cellucci A; Bracacel E; Auciello G; Veneziano M; Khetarpal V; Rose M; Rosa A; Gloaguen I; Monteagudo E; Herbst T; Dominguez C; Muñoz-Sanjuán I
Cells; 2020 Apr; 9(4):. PubMed ID: 32316221
[TBL] [Abstract][Full Text] [Related]
9. Enhanced xeno-free differentiation of hiPSC-derived astroglia applied in a blood-brain barrier model.
Delsing L; Kallur T; Zetterberg H; Hicks R; Synnergren J
Fluids Barriers CNS; 2019 Aug; 16(1):27. PubMed ID: 31462266
[TBL] [Abstract][Full Text] [Related]
10. An isogenic blood-brain barrier model comprising brain endothelial cells, astrocytes, and neurons derived from human induced pluripotent stem cells.
Canfield SG; Stebbins MJ; Morales BS; Asai SW; Vatine GD; Svendsen CN; Palecek SP; Shusta EV
J Neurochem; 2017 Mar; 140(6):874-888. PubMed ID: 27935037
[TBL] [Abstract][Full Text] [Related]
11. Role of iPSC-derived pericytes on barrier function of iPSC-derived brain microvascular endothelial cells in 2D and 3D.
Jamieson JJ; Linville RM; Ding YY; Gerecht S; Searson PC
Fluids Barriers CNS; 2019 Jun; 16(1):15. PubMed ID: 31167667
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Modeling of Blood-Brain Barrier with Human iPSC-Derived Endothelial Cells, Pericytes, Neurons, and Astrocytes via Notch Signaling.
Yamamizu K; Iwasaki M; Takakubo H; Sakamoto T; Ikuno T; Miyoshi M; Kondo T; Nakao Y; Nakagawa M; Inoue H; Yamashita JK
Stem Cell Reports; 2017 Mar; 8(3):634-647. PubMed ID: 28238797
[TBL] [Abstract][Full Text] [Related]
13. Generation of an hiPSC-Derived Co-Culture System to Assess the Effects of Neuroinflammation on Blood-Brain Barrier Integrity.
Bull D; Schweitzer C; Bichsel C; Britschgi M; Gutbier S
Cells; 2022 Jan; 11(3):. PubMed ID: 35159229
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a Human iPSC- and Nanofiber-Based Microphysiological Blood-Brain Barrier System.
Qi D; Wu S; Lin H; Kuss MA; Lei Y; Krasnoslobodtsev A; Ahmed S; Zhang C; Kim HJ; Jiang P; Duan B
ACS Appl Mater Interfaces; 2018 Jul; 10(26):21825-21835. PubMed ID: 29897225
[TBL] [Abstract][Full Text] [Related]
15. Advancing human induced pluripotent stem cell-derived blood-brain barrier models for studying immune cell interactions.
Nishihara H; Gastfriend BD; Soldati S; Perriot S; Mathias A; Sano Y; Shimizu F; Gosselet F; Kanda T; Palecek SP; Du Pasquier R; Shusta EV; Engelhardt B
FASEB J; 2020 Dec; 34(12):16693-16715. PubMed ID: 33124083
[TBL] [Abstract][Full Text] [Related]
16. A Human Neurovascular Unit On-a-Chip.
Lee SWL; Rogosic R; Venturi C; Raimondi MT; Pavesi A; Adriani G
Methods Mol Biol; 2022; 2373():107-119. PubMed ID: 34520009
[TBL] [Abstract][Full Text] [Related]
17. Defined Differentiation of Human Pluripotent Stem Cells to Brain Microvascular Endothelial-Like Cells for Modeling the Blood-Brain Barrier.
Foreman KL; Shusta EV; Palecek SP
Methods Mol Biol; 2023; 2683():113-133. PubMed ID: 37300771
[TBL] [Abstract][Full Text] [Related]
18. Modeling and rescue of defective blood-brain barrier function of induced brain microvascular endothelial cells from childhood cerebral adrenoleukodystrophy patients.
Lee CAA; Seo HS; Armien AG; Bates FS; Tolar J; Azarin SM
Fluids Barriers CNS; 2018 Apr; 15(1):9. PubMed ID: 29615068
[TBL] [Abstract][Full Text] [Related]
19. Differentiation and characterization of human pluripotent stem cell-derived brain microvascular endothelial cells.
Stebbins MJ; Wilson HK; Canfield SG; Qian T; Palecek SP; Shusta EV
Methods; 2016 May; 101():93-102. PubMed ID: 26518252
[TBL] [Abstract][Full Text] [Related]
20. Accelerated differentiation of human induced pluripotent stem cells to blood-brain barrier endothelial cells.
Hollmann EK; Bailey AK; Potharazu AV; Neely MD; Bowman AB; Lippmann ES
Fluids Barriers CNS; 2017 Apr; 14(1):9. PubMed ID: 28407791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
